XIAOMI-W
01810
BABA-W
09988
ALI HEALTH
00241
KUAISHOU-W
01024
BIDU-SW
09888
(Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | (Q6)Sep 30, 2020 | (FY)Mar 31, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 9.70%407.91M | 171.11%789.26M | 242.51%371.84M | -30.00%291.12M | 47.41%108.56M | 37.78%415.89M | -20.70%73.65M | -73.60%301.86M | -86.30%92.88M | -17.24%1.14B |
Operating income | 9.70%407.91M | 171.11%789.26M | 242.51%371.84M | -30.00%291.12M | 47.41%108.56M | 37.78%415.89M | -20.70%73.65M | -73.60%301.86M | -86.30%92.88M | -17.24%1.14B |
Cost of sales | -0.55%-23.97M | -36.50%-49.26M | -49.33%-23.84M | -12.75%-36.09M | -28.22%-15.96M | -90.60%-32M | -91.54%-12.45M | 50.30%-16.79M | 66.09%-6.5M | 14.50%-33.78M |
Other costs | -4.57%-224.1M | -16.57%-432.15M | -1.53%-214.31M | 20.64%-370.72M | -103.15%-211.08M | -20.24%-467.16M | 46.66%-103.91M | 21.56%-388.51M | 22.30%-194.8M | 1.65%-495.3M |
Operating expenses | -4.17%-248.07M | -18.34%-481.41M | -4.89%-238.15M | 18.50%-406.81M | -95.13%-227.05M | -23.16%-499.16M | 42.20%-116.36M | 23.40%-405.3M | 25.41%-201.3M | 2.59%-529.08M |
Gross profit | 19.56%159.84M | 366.10%307.85M | 212.84%133.69M | -38.94%-115.69M | -177.42%-118.48M | 19.50%-83.27M | 60.61%-42.71M | -116.84%-103.44M | -126.57%-108.43M | -26.73%614.15M |
Selling expenses | -25.50%-79.53M | -316.61%-146.37M | -477.07%-63.37M | 51.93%-35.13M | -871.86%-10.98M | -23.91%-73.09M | 91.10%-1.13M | 72.22%-58.99M | 89.99%-12.7M | 26.41%-212.36M |
Administrative expenses | -10.17%-66.33M | -3.77%-125.36M | 11.28%-60.21M | 31.35%-120.81M | -158.96%-67.87M | -9.87%-175.99M | 66.45%-26.21M | 34.81%-160.19M | 35.35%-78.11M | 1.58%-245.74M |
Revaluation surplus | -18,949.43%-263.89M | -203.05%-20.3M | 104.50%1.4M | 113.78%19.7M | -183.38%-31.1M | -297.22%-143M | 360.84%37.3M | 1.10%-36M | -176.06%-14.3M | -306.82%-36.4M |
-Changes in the fair value of investment property | -18,949.43%-263.89M | -203.05%-20.3M | 104.50%1.4M | 113.78%19.7M | -183.38%-31.1M | -297.22%-143M | 360.84%37.3M | 1.10%-36M | -176.06%-14.3M | -306.82%-36.4M |
Impairment and provision | --590K | ---- | ---- | 111.50%31.19M | ---590K | -273,958.59%-271.12M | ---- | -74.29%99K | -70.19%79K | 101.10%385K |
-Impairment of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | ---271.12M | ---- | ---- | ---- | ---- |
-Other impairment is provision | --590K | ---- | ---- | --31.19M | ---590K | ---- | ---- | -74.29%99K | -70.19%79K | 101.10%385K |
Special items of operating profit | 222.70%28.26M | -49.16%20.66M | -73.52%8.76M | 72.97%40.64M | 116.85%33.08M | -57.61%23.5M | -52.36%15.25M | -37.73%55.42M | -28.87%32.02M | 4.44%89.01M |
Operating profit | -1,191.10%-221.07M | 120.26%36.48M | 110.34%20.26M | 75.09%-180.1M | -1,020.13%-195.95M | -138.53%-722.98M | 90.36%-17.49M | -244.99%-303.09M | -180.86%-181.44M | -43.14%209.04M |
Financing cost | 11.98%-529K | 3.25%-1.07M | -6.94%-601K | 41.88%-1.11M | 58.92%-562K | -54.49%-1.91M | -83.62%-1.37M | 47.09%-1.24M | 51.08%-745K | -1,264.91%-2.33M |
Earning before tax | -1,227.14%-221.6M | 119.54%35.41M | 110.00%19.66M | 75.00%-181.21M | -941.87%-196.51M | -138.19%-724.89M | 89.65%-18.86M | -247.23%-304.33M | -181.75%-182.18M | -43.75%206.71M |
Tax | 45.96%-4.09M | -48.47%27.42M | -235.90%-7.57M | -34.01%53.21M | 177.62%5.57M | 0.95%80.64M | -74.38%2.01M | 5.47%79.88M | 134.58%7.83M | 6.94%75.74M |
After-tax profit from continuing operations | -1,966.41%-225.69M | 149.09%62.83M | 106.33%12.09M | 80.13%-128M | -1,032.83%-190.94M | -187.03%-644.25M | 90.33%-16.86M | -179.47%-224.45M | -187.08%-174.35M | -35.56%282.45M |
After-tax profit from non-continuing business | ---- | ---- | ---- | ---- | ---- | ---- | ---86.02M | ---- | ---- | ---- |
Earning after tax | -1,966.41%-225.69M | 149.09%62.83M | 106.33%12.09M | 80.13%-128M | -85.60%-190.94M | -187.03%-644.25M | 41.00%-102.87M | -179.47%-224.45M | -187.08%-174.35M | -35.56%282.45M |
Minority shareholders should account for profits from continuing business | ---- | ---- | ---- | ---- | ---- | ---- | ---1.85M | ---- | ---- | ---- |
Minority shareholders should account for non-continuing business profits | ---- | ---- | ---- | ---- | ---- | ---- | ---17.06M | ---- | ---- | ---- |
Minority profit | -17,804.81%-47.8M | 106.53%1.95M | 100.77%270K | 74.29%-29.81M | -86.61%-35.28M | -147.32%-115.93M | 41.90%-18.91M | -352.96%-46.87M | -241.37%-32.54M | -73.83%18.53M |
Shareholders should account for profits from continuing business | ---- | ---- | ---- | ---- | ---- | ---- | ---15.01M | ---- | ---- | ---- |
Shareholders should account for profits from non-continuing business | ---- | ---- | ---- | ---- | ---- | ---- | ---68.96M | ---- | ---- | ---- |
Profit attributable to shareholders | -1,604.68%-177.88M | 162.01%60.89M | 107.59%11.82M | 81.41%-98.19M | -85.38%-155.66M | -197.52%-528.32M | 40.79%-83.97M | -167.29%-177.58M | -180.03%-141.81M | -28.18%263.92M |
Basic earnings per share | -1,600.00%-0.15 | 162.50%0.05 | 107.69%0.01 | 81.82%-0.08 | -85.71%-0.13 | -193.33%-0.44 | 41.67%-0.07 | -171.43%-0.15 | -185.71%-0.12 | -27.59%0.21 |
Diluted earnings per share | ||||||||||
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.